The rate of decline in small fibre function assessed using axon reflex-mediated neurogenic vasodilatation and the importance of age related centile values to improve the detection of clinical neuropathy

Prashanth R J Vas, Gerry Rayman, Prashanth R J Vas, Gerry Rayman

Abstract

Background: The LDIflare technique (LDIflare) is a simple non-invasive test of small fibre function in dorsal foot skin involving skin heating and measuring the size of the resulting axon reflex-mediated vasodilator (flare) response using a laser Doppler imager (LDI). This study establishes age-related normative reference ranges for the test and determines the rate of decline in small fibre function per decade. Additionally, the potential value of using age related centiles rather than Receiver Operator Curves (ROC) was explored by comparison of the sensitivity and specificity of each analytic technique in identifying clinical neuropathy.

Methods: LDIflare areas were assessed in 94 healthy controls and 66 individuals with diabetes with (DN+, n = 31) and without clinical neuropathy (DN-, n = 35); neuropathy defined as a Neuropathy Disability Score ≥ 3. The age specific 5th centile values were used as the 'cut-offs' for the diagnosis of neuropathy from which sensitivity and specificity were calculated.

Results: There was a significant age dependant decrease in LDIflare size (r = -0.42, p<0.0001) with no significant gender differences. The LDIflare size reduced 0.56 cm(2) per decade which gives a percentage reduction of approximately 5.5% per decade. Using the normative 5th centiles as the cut-offs, the technique had a sensitivity of 77%, specificity of 90%, positive predictive value of 82% and negative predictive value of 87%.The ROC analysis gave a threshold of <3.66 cm(2) for the cut-off, resulting in a sensitivity of 75%, specificity of 85%, positive predictive value of 74% and negative predictive value of 86%.

Conclusions: There is an age dependent decrease in small fibre function in the foot of 5.5% per decade. Both analytic techniques demonstrate good sensitivity and specificity for detecting clinical neuropathy but the technique based on age centiles offers better diagnostic accuracy and is therefore proposed as the method of choice.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Relationship of the LDIflare (cm…
Figure 1. Relationship of the LDIflare (cm2) to age (years), r = −0.42, P<0.0001.
The lines above and below the trendline describe the 95th and 5th centiles respectively.
Figure 2. LDIflare relationship between the 3…
Figure 2. LDIflare relationship between the 3 groups.
Green dots are the healthy controls (HC, flare area 9.2±2.9 cm2), amber dots are subjects with Diabetes but without clinical neuropathy (DN-, 6.9±2.79 cm2) and red dots the subjects with diabetes and clinical neuropathy (DN+, 2.7±0.9 cm2).

References

    1. Boulton AJ, Malik RA (2010) Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care 33: 207–209.
    1. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, et al. (2006) Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29: 1294–1299.
    1. Krishnan ST, Rayman G (2004) The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 27: 2930–2935.
    1. Tavakoli M, Marshall A, Pitceathly R, Fadavi H, Gow D, et al... (2009) Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol.
    1. Maser RE, Nielsen VK, Bass EB, Manjoo Q, Dorman JS, et al. (1989) Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12: 270–275.
    1. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, et al. (2003) Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60: 898–904.
    1. Freeman R, Chase KP, Risk MR (2003) Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 60: 465–470.
    1. Tavakoli M, Quattrini C, Abbott C, Kallinikos P, Marshall A, et al. (2010) Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 33: 1792–1797.
    1. Green AQ (2010) Small fibre function assessed using the LDI flare technique in subjects with type 1 diabetes mellitus and impaired glucose tolerance. 146.
    1. Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G (2009) Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy. Diabetes Care 32: 451–455.
    1. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW (1998) Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 55: 1513–1520.
    1. Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, et al. (2007) Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 35: 591–598.
    1. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, et al. (2010) Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15: 202–207.
    1. Boulton AJM (2005) Management of Diabetic Peripheral Neuropathy. Clinical Diabetes 23: 9–15.
    1. Bril V, Perkins BA (2002) Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy. Diabetes Care 25: 2048–2052.
    1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, et al. (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19: 377–384.
    1. Bril V, Perkins BA (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25: 2048–2052.
    1. Vas PR, Rayman G (2012) Validation of the modified LDIFLARE technique: A simple and quick method to assess C-fiber function. Muscle Nerve.
    1. Wright EM, Royston P (1999) Calculating reference intervals for laboratory measurements. Statistical Methods in Medical Research 8: 93–112.
    1. Bewick V, Cheek L, Ball J (2004) Statistics review 13: Receiver operating characteristic curves. Critical Care 8: 508–512.
    1. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, et al. (2009) Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73: 1142–1148.
    1. Bravenboer B, van Dam PS, Hop J, v.d. Steenhoven J, Erkelens DW (1992) Thermal Threshold Testing for the Assessment of Small Fibre Dysfunction: Normal Values and Reproducibility. Diabetic Medicine 9: 546–549.
    1. Gibbons CH, Freeman R, Veves A (2010) Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care 33: 2629–2634.
    1. Nabavi Nouri M, Ahmed A, Bril V, Orszag A, Ng E, et al. (2012) Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One 7: e34807.
    1. Green AQ, Krishnan ST, Rayman G (2009) C-fiber function assessed by the laser doppler imager flare technique and acetylcholine iontophoresis. Muscle Nerve 40: 985–991.
    1. Green AQ, Krishnan S, Finucane FM, Rayman G (2010) Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care 33: 174–176.
    1. Ebadi H, Perkins BA, Katzberg HD, Lovblom LE, Bril V (2012) Evaluation of proxy tests for SFSN: evidence for mixed small and large fiber dysfunction. PLoS One 7: e42208.
    1. Rolke R, Baron R, Maier C, Tolle TR, Treede RD, et al. (2006) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123: 231–243.
    1. Blankenburg M, Boekens H, Hechler T, Maier C, Krumova E, et al. (2010) Reference values for quantitative sensory testing in children and adolescents: developmental and gender differences of somatosensory perception. Pain 149: 76–88.

Source: PubMed

3
Prenumerera